In plain words
In most trials, people who took L-theanine alone scored no better on thinking tests than people given a placebo. One trial found faster reactions, and another found a possible benefit from a product called LGNC-07. One found fewer correct answers on a subtraction test.
The short answer
Evidence leans to no effect of L-theanine alone. Four of the seven trials found no difference from placebo: 200 mg daily for 4 weeks in 30 adults; 50 mg in 24 adults (no duration in the ledger); one 200 mg drink (no n in the ledger); 12 weeks in 69 people (no dose in the ledger). One 250 mg dose in 24 adults lowered correct subtractions. Two found gains: faster reactions after one 100.6 mg dose in 50 people, and a 16-week trial of 1,680 mg LGNC-07 in 91 people that suggests potential. Certainty is low, because the trials are small, mostly single-dose and use different tests.
Where the evidence sits
Better than placebo
No difference from placebo
Worse than placebo
■ measured by the source's own study · ◪ pooled analysis, may overlap studies counted here · □ reported, reviewed or argued, no new data
Who says what
| Source | Finding | Design | People | Dose and length | Funding and independence |
|---|---|---|---|---|---|
| Hidese, 2019 | No difference | Randomized | 30 | 200 mg, 4 weeks | Not in ledger |
| Dodd, 2015 | No effect | Randomized | 24 | 50 mg | Not in ledger |
| Haskell, 2007 | Fewer correct subtractions | Crossover | 24 | 250 mg once | Not in ledger |
| White, 2016 | No change | Randomized | Not in ledger | 200 mg once | Not in ledger |
| Park, 2011 | Suggests potential | Randomized, LGNC-07 | 91 | 1,680 mg, 16 weeks | Not in ledger |
| Mátyus, 2025 | Mixed reaction times | Pooled; may include above | 148 | Single doses | Not in ledger |
| Alzheimer's Drug Discovery Foundation, 2025 | No effect | Foundation describing trials | 30; 69 | 4; 12 weeks | Not in ledger |
No difference
No effect
Fewer correct subtractions
No change
Suggests potential
Mixed reaction times
No effect
Did one dose change test scores?
White and colleagues (2016) gave a drink with 200 mg of L-theanine or a placebo once. The ledger has no n for this trial:
No treatment-related cognitive performance changes were observed.
Dodd and colleagues (2015) found no effect of 50 mg alone in 24 adults, and the ledger has no duration for it. After one 250 mg dose in 24 adults, Haskell and colleagues (2007) recorded fewer correct serial seven subtractions. Mátyus and colleagues (2025) describe a trial by Baba and colleagues in which 50 people given one 100.6 mg dose had faster simple reaction times than the placebo group. Their pooled estimate may include the trials above. It found that single doses of 50 to 400 mg did not change simple reaction time in 126 adults, while higher single doses up to 400 mg sped two other reaction tests in 148 adults.
Did weeks of daily use do better?
Hidese and colleagues (2019) gave 30 healthy adults 200 mg a day or a placebo for four weeks. Verbal fluency and executive function scores rose from baseline, but not against placebo:
When score changes were compared between the L-theanine and placebo administrations, no significant difference was found for any cognitive function.
The Alzheimer's Drug Discovery Foundation (2025) describes a four-week trial in 30 middle-aged people with no difference on 12 cognitive outcomes, which appears to describe the same trial. It also describes a 12-week trial in 69 people aged 50 to 69 with no significant effect. The ledger has no dose for either. Park and colleagues (2011) gave 91 people 1,680 mg of a product named LGNC-07 for 16 weeks and wrote that their study suggests it has potential for cognitive improvement.
Why the sources disagree
Dose, length (one dose or several weeks) and test (reaction time to verbal fluency) differ across studies. Hidese's scores rose from baseline but not against placebo. Park tested LGNC-07. Baba's trial and the 12-week trial reach the ledger only through other sources. Mátyus's pooled estimate may include the trials above.
What would settle it
An independent placebo-controlled trial of L-theanine alone at 200 mg a day for 12 weeks in at least 200 healthy adults would settle it. The trial would register its cognitive tests and main outcome in advance and report results against placebo rather than baseline. A matching result from a second research group would raise certainty from low to moderate.
How this page was made
The 7 sources are five studies of L-theanine and cognition, a 2025 meta-analysis that may include them, and the Alzheimer's Drug Discovery Foundation's 2025 evidence rating, found through a medical literature search. Studies in people with schizophrenia, depression, anxiety disorder or ADHD were left out. Every claim was copied word for word into the Longevity Circle ledger, checked against the original text and approved by a person. Certainty follows GRADE levels. Drafting was assisted by AI.
Changelog: 30 Sep 2026, first version, 7 sources.
